GLYCERIN SUPPOSITORY

GLYCERIN SUPPOSITORY was reported 2650 times

GLYCERIN SUPPOSITORY is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 VAGINAL FLATULENCE 155 0.5116
1 EOSINOPHIL COUNT NORMAL 3 0.2143
2 FIBULA AGENESIS 4 0.1600
3 HAEMOPHILUS SEPSIS 6 0.1053
4 FEMALE GENITAL TRACT FISTULA 158 0.0925
5 MULTIPLE DRUG THERAPY 54 0.0716
6 CREATININE RENAL CLEARANCE INCREASED 52 0.0695
7 AUTOIMMUNE ENTEROPATHY 6 0.0682
8 CHRONIC SINUSITIS 227 0.0604
9 SEDATION COMPLICATION 153 0.0599
10 RADICULOPATHY 155 0.0588
11 PROCTITIS 156 0.0556
12 MACULAR DEGENERATION 599 0.0501
13 CREATININE RENAL CLEARANCE DECREASED 163 0.0407
14 SPINA BIFIDA OCCULTA 4 0.0381
15 GALLBLADDER ADENOCARCINOMA 2 0.0282
16 BACTERIAL TRACHEITIS 2 0.0247
17 TRACHEOSTOMY INFECTION 3 0.0246
18 INFANT IRRITABILITY 2 0.0204
19 FALSE POSITIVE INVESTIGATION RESULT 19 0.0188
20 ANAL EROSION 2 0.0182
21 CLOSTRIDIUM DIFFICILE SEPSIS 2 0.0179
22 POSITIVE AIRWAY PRESSURE THERAPY 5 0.0171
23 INCARCERATED INGUINAL HERNIA 2 0.0164
24 MYELOCYTE COUNT INCREASED 3 0.0160
25 OESOPHAGEAL INJURY 6 0.0155
26 VAGINAL DISCHARGE 155 0.0153
27 BLOOD TESTOSTERONE FREE DECREASED 2 0.0153
28 RENAL FUNCTION TEST ABNORMAL 69 0.0148
29 NASAL FLARING 2 0.0148
30 BLOOD CALCIUM DECREASED 166 0.0147
31 PARAESTHESIA ORAL 212 0.0147
32 METAMYELOCYTE COUNT INCREASED 2 0.0134
33 LACK OF ADMINISTRATION SITE ROTATION 4 0.0131
34 BACTERIAL TRANSLOCATION 4 0.0126
35 ORAL CANDIDIASIS 158 0.0120
36 TOOTH DEPOSIT 4 0.0115
37 BILE ACIDS INCREASED 2 0.0113
38 FAT TISSUE DECREASED 4 0.0103
39 FIBRIN DEGRADATION PRODUCTS INCREASED 3 0.0101
40 GASTROSTOMY TUBE SITE COMPLICATION 2 0.0100
41 RENAL ABSCESS 8 0.0098
42 ORTHOSTATIC HYPOTENSION 167 0.0096
43 HAEMORRHAGIC EROSIVE GASTRITIS 3 0.0092
44 MAGNESIUM DEFICIENCY 4 0.0085
45 KIDNEY MALFORMATION 3 0.0085
46 IDIOPATHIC INTERSTITIAL PNEUMONIA 3 0.0085
47 NEUROGENIC BOWEL 2 0.0084
48 BRAIN NEOPLASM BENIGN 4 0.0078
49 ALLERGIC COUGH 6 0.0078
50 INJECTION RELATED REACTION 12 0.0073
51 USE OF ACCESSORY RESPIRATORY MUSCLES 3 0.0073
52 PROCEDURAL PAIN 197 0.0071
53 HYPOAESTHESIA EYE 4 0.0068
54 FEEDING INTOLERANCE 3 0.0067
55 NEPHRITIC SYNDROME 2 0.0065
56 SEDATION 158 0.0060
57 SUPERINFECTION 9 0.0060
58 FREQUENT BOWEL MOVEMENTS 160 0.0059
59 CHRONIC RESPIRATORY DISEASE 2 0.0057
60 ANISOCORIA 2 0.0053
61 RED BLOOD CELLS URINE POSITIVE 5 0.0052
62 VOLVULUS 12 0.0051
63 ALVEOLAR OSTEITIS 2 0.0047
64 HYPERMAGNESAEMIA 3 0.0046
65 COLITIS 171 0.0045
66 DEPRESSED LEVEL OF CONSCIOUSNESS 177 0.0045
67 IMMUNE-MEDIATED HYPOPHYSITIS 2 0.0044
68 IMMUNOGLOBULINS INCREASED 2 0.0043
69 KLEBSIELLA BACTERAEMIA 4 0.0042
70 ANTIBODY TEST ABNORMAL 3 0.0042
71 OROMANDIBULAR DYSTONIA 3 0.0041
72 BLOOD CORTICOTROPHIN DECREASED 2 0.0041
73 ASTIGMATISM 6 0.0040
74 TRACHEITIS 3 0.0039
75 RESPIRATORY SYNCYTIAL VIRUS BRONCHIOLITIS 3 0.0038
76 BLOOD FIBRINOGEN INCREASED 3 0.0038
77 INFUSION SITE CELLULITIS 2 0.0038
78 RECTAL HAEMORRHAGE 162 0.0038
79 FAECAL VOMITING 2 0.0038
80 COGNITIVE DISORDER 171 0.0037
81 COLITIS ULCERATIVE 160 0.0036
82 CARBON DIOXIDE DECREASED 4 0.0035
83 PUSTULE 8 0.0034
84 INFUSION RELATED REACTION 214 0.0032
85 BILIARY TRACT INFECTION 2 0.0032
86 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 228 0.0032
87 PYELONEPHRITIS ACUTE 6 0.0031
88 HAEMATOCHEZIA 168 0.0030
89 FEELING OF RELAXATION 2 0.0029
90 SUBILEUS 6 0.0029
91 ENDOMETRIAL CANCER 6 0.0027
92 CLOSTRIDIUM TEST POSITIVE 6 0.0027
93 AORTIC ARTERIOSCLEROSIS 7 0.0027
94 LOCAL REACTION 2 0.0027
95 HYPOPROTEINAEMIA 5 0.0026
96 GASTROINTESTINAL SURGERY 2 0.0026
97 RHINOVIRUS INFECTION 10 0.0026
98 BILIRUBIN CONJUGATED INCREASED 6 0.0026
99 ELECTROCARDIOGRAM REPOLARISATION ABNORMALITY 2 0.0026
100 HYPOCHLORAEMIA 3 0.0026
101 FOETAL GROWTH RETARDATION 2 0.0026
102 METAPNEUMOVIRUS INFECTION 2 0.0026
103 UPPER RESPIRATORY TRACT INFLAMMATION 3 0.0025
104 ATYPICAL HAEMOLYTIC URAEMIC SYNDROME 2 0.0025
105 MONOCYTE COUNT DECREASED 3 0.0025
106 TUMOUR HAEMORRHAGE 7 0.0025
107 MOBILITY DECREASED 175 0.0024
108 DOCUMENTED HYPERSENSITIVITY TO ADMINISTERED PRODUCT 2 0.0024
109 INTRA-ABDOMINAL HAEMATOMA 3 0.0024
110 OESOPHAGEAL PERFORATION 2 0.0024
111 OESOPHAGEAL RUPTURE 2 0.0024
112 FAECALOMA 13 0.0024
113 ENTEROVIRUS INFECTION 2 0.0023
114 BLADDER DISORDER 23 0.0023
115 BLOOD CHLORIDE INCREASED 4 0.0023
116 TUMOUR PAIN 3 0.0023
117 BRONCHIOLITIS 8 0.0023
118 INTESTINAL DILATATION 3 0.0022
119 GASTROINTESTINAL INJURY 6 0.0022
120 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 2 0.0022
121 BLOOD ALKALINE PHOSPHATASE DECREASED 2 0.0021
122 INJECTION SITE HYPOAESTHESIA 3 0.0021
123 POST HERPETIC NEURALGIA 3 0.0021
124 DYSPEPSIA 205 0.0021
125 PNEUMONIA CYTOMEGALOVIRAL 4 0.0021
126 CONSTIPATION 449 0.0021
127 ANIMAL SCRATCH 2 0.0021
128 NEUTROPHIL COUNT INCREASED 21 0.0020
129 PSYCHIATRIC DECOMPENSATION 4 0.0020
130 MASTOIDITIS 2 0.0020
131 RESPIRATORY ACIDOSIS 8 0.0020
132 BALANCE DISORDER 173 0.0020
133 LUNG ADENOCARCINOMA 6 0.0020
134 SMALL CELL LUNG CANCER 3 0.0020
135 SECONDARY ADRENOCORTICAL INSUFFICIENCY 3 0.0020
136 KLEBSIELLA INFECTION 10 0.0020
137 EYE ALLERGY 3 0.0019
138 BLOOD PHOSPHORUS DECREASED 7 0.0019
139 HEPATITIS E 3 0.0019
140 TINEA PEDIS 3 0.0019
141 NEUROMYOPATHY 2 0.0019
142 KIDNEY ENLARGEMENT 2 0.0018
143 INFLAMMATORY MARKER INCREASED 9 0.0018
144 TROPONIN I INCREASED 3 0.0018
145 TONGUE BLISTERING 4 0.0018
146 PSEUDOMEMBRANOUS COLITIS 4 0.0018
147 ENTERITIS INFECTIOUS 3 0.0018
148 MOUTH SWELLING 10 0.0017
149 HYPERURICAEMIA 7 0.0017
150 INCISION SITE PAIN 2 0.0017
151 FACIAL PARESIS 6 0.0017
152 HISTIOCYTOSIS HAEMATOPHAGIC 5 0.0017
153 SCHIZOAFFECTIVE DISORDER 3 0.0017
154 INFECTED CYST 2 0.0017
155 ARTERIOSCLEROSIS CORONARY ARTERY 11 0.0017
156 CHRONIC RESPIRATORY FAILURE 2 0.0017
157 HYPERNATRAEMIA 8 0.0016
158 ADENOCARCINOMA OF COLON 3 0.0016
159 NECROTISING COLITIS 2 0.0016
160 RADIOTHERAPY 3 0.0016
161 PNEUMONIA VIRAL 5 0.0016
162 PNEUMONIA ASPIRATION 39 0.0016
163 ANAEMIA POSTOPERATIVE 2 0.0015
164 ABDOMINAL RIGIDITY 4 0.0015
165 DECUBITUS ULCER 12 0.0015
166 LYMPHOCYTE COUNT DECREASED 26 0.0015
167 NASAL DISCHARGE DISCOLOURATION 2 0.0014
168 BUNDLE BRANCH BLOCK LEFT 6 0.0014
169 DIABETIC FOOT INFECTION 2 0.0014
170 INTENSIVE CARE 2 0.0014
171 PROTEIN URINE PRESENT 7 0.0014
172 PNEUMATOSIS INTESTINALIS 4 0.0014
173 NEUROLOGICAL SYMPTOM 8 0.0014
174 BLOOD ALBUMIN DECREASED 11 0.0014
175 IMMUNE-MEDIATED ENTEROCOLITIS 5 0.0014
176 GINGIVAL SWELLING 6 0.0014
177 CONJUNCTIVITIS ALLERGIC 2 0.0013
178 TEMPERATURE REGULATION DISORDER 3 0.0013
179 ILEUS PARALYTIC 6 0.0013
180 LARGE INTESTINAL OBSTRUCTION 3 0.0013
181 GASTROINTESTINAL HYPOMOTILITY 3 0.0013
182 CALCULUS URINARY 2 0.0013
183 ANAL ABSCESS 7 0.0013
184 FUNGAEMIA 2 0.0013
185 INGROWING NAIL 3 0.0013
186 URINE OUTPUT DECREASED 11 0.0013
187 METASTASES TO CENTRAL NERVOUS SYSTEM 16 0.0012
188 COSTOCHONDRITIS 2 0.0012
189 BRADYARRHYTHMIA 2 0.0012
190 ANAEMIA 232 0.0012
191 OTITIS MEDIA 4 0.0012
192 ILEUS 15 0.0012
193 SKIN REACTION 17 0.0012
194 FLUID INTAKE REDUCED 6 0.0012
195 MYOCARDIAL NECROSIS MARKER INCREASED 2 0.0012
196 ABSCESS LIMB 5 0.0012
197 GLIOBLASTOMA 2 0.0012
198 PSEUDOMONAS INFECTION 10 0.0012
199 PYELONEPHRITIS 10 0.0012
200 LUNG OPACITY 3 0.0011
201 DISSEMINATED INTRAVASCULAR COAGULATION 16 0.0011
202 CYTOMEGALOVIRUS TEST POSITIVE 2 0.0011
203 LARYNGOSPASM 3 0.0011
204 BLOOD SODIUM INCREASED 3 0.0011
205 DEMENTIA 31 0.0011
206 IMMUNE-MEDIATED LUNG DISEASE 2 0.0011
207 STOMA SITE DISCHARGE 3 0.0011
208 ESSENTIAL HYPERTENSION 2 0.0011
209 CONDUCTION DISORDER 2 0.0011
210 PROCTALGIA 7 0.0011
211 UROSEPSIS 10 0.0011
212 ABDOMINAL PAIN 252 0.0011
213 RASH MORBILLIFORM 3 0.0011
214 BLOOD IRON INCREASED 2 0.0011
215 PROTEIN TOTAL DECREASED 4 0.0011
216 PARANASAL SINUS DISCOMFORT 4 0.0011
217 GINGIVAL RECESSION 2 0.0010
218 TOXICITY TO VARIOUS AGENTS 175 0.0010
219 RESPIRATORY SYNCYTIAL VIRUS INFECTION 9 0.0010
220 OCCULT BLOOD POSITIVE 2 0.0010
221 ERYTHEMA 209 0.0010
222 STAPHYLOCOCCAL SEPSIS 5 0.0010
223 HEPATITIS FULMINANT 3 0.0010
224 CEREBRAL ATROPHY 4 0.0010
225 ANORECTAL DISORDER 2 0.0010
226 BLOOD CULTURE POSITIVE 3 0.0010
227 GASTROINTESTINAL PAIN 11 0.0010
228 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 5 0.0010
229 DYSAESTHESIA 3 0.0010
230 HYPOTENSION 196 0.0010
231 DIVERTICULAR PERFORATION 2 0.0010
232 WEIGHT DECREASED 270 0.0010
233 GASTROINTESTINAL PERFORATION 4 0.0010
234 INFUSION SITE SWELLING 6 0.0010
235 EOSINOPHILIC PNEUMONIA 3 0.0010
236 UPPER GASTROINTESTINAL HAEMORRHAGE 16 0.0010
237 NEUROGENIC BLADDER 2 0.0009
238 HYDRONEPHROSIS 7 0.0009
239 ACUTE MYELOID LEUKAEMIA RECURRENT 2 0.0009
240 SKIN EROSION 3 0.0009
241 TEARFULNESS 4 0.0009
242 BLOOD PRESSURE SYSTOLIC INCREASED 18 0.0009
243 ASTHENOPIA 5 0.0009
244 HYPOALBUMINAEMIA 7 0.0009
245 PYREXIA 311 0.0009
246 RHINITIS ALLERGIC 4 0.0009
247 BACTERIAL TEST POSITIVE 2 0.0009
248 SKIN INFECTION 10 0.0009
249 COLITIS ISCHAEMIC 6 0.0009
250 COMPLICATIONS OF TRANSPLANTED KIDNEY 2 0.0009
251 THERAPEUTIC PRODUCT EFFECT DELAYED 4 0.0009
252 WOUND COMPLICATION 3 0.0009
253 PNEUMONIA BACTERIAL 8 0.0009
254 CLOSTRIDIUM DIFFICILE COLITIS 9 0.0008
255 HYPOCALCAEMIA 16 0.0008
256 DIVERTICULUM 6 0.0008
257 FIBRIN D DIMER INCREASED 3 0.0008
258 BLOOD UREA INCREASED 14 0.0008
259 LACUNAR INFARCTION 2 0.0008
260 NON-SMALL CELL LUNG CANCER 4 0.0008
261 LONG QT SYNDROME 2 0.0008
262 INFUSION SITE ERYTHEMA 7 0.0008
263 ORAL INTAKE REDUCED 2 0.0008
264 MONOCYTE COUNT INCREASED 3 0.0008
265 THROMBOCYTOSIS 3 0.0008
266 BREATH SOUNDS ABNORMAL 4 0.0008
267 ACUTE PSYCHOSIS 2 0.0008
268 GASTROINTESTINAL SOUNDS ABNORMAL 4 0.0008
269 BRAIN OEDEMA 10 0.0008
270 HYPOMAGNESAEMIA 11 0.0008
271 EXCORIATION 2 0.0008
272 APHONIA 11 0.0008
273 ABDOMINAL INFECTION 2 0.0008
274 INCREASED BRONCHIAL SECRETION 2 0.0008
275 EJECTION FRACTION DECREASED 12 0.0008
276 COMPARTMENT SYNDROME 2 0.0008
277 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 2 0.0008
278 FEBRILE NEUTROPENIA 50 0.0008
279 GASTROINTESTINAL MOTILITY DISORDER 4 0.0007
280 ENURESIS 3 0.0007
281 EAR CONGESTION 2 0.0007
282 SPUTUM DISCOLOURED 7 0.0007
283 SHOCK HAEMORRHAGIC 6 0.0007
284 HYDROCEPHALUS 4 0.0007
285 HICCUPS 6 0.0007
286 ORAL FUNGAL INFECTION 2 0.0007
287 NEPHROTIC SYNDROME 5 0.0007
288 ATELECTASIS 7 0.0007
289 DROOLING 5 0.0007
290 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 2 0.0007
291 HEPATIC FUNCTION ABNORMAL 27 0.0007
292 GASTRIC ULCER HAEMORRHAGE 4 0.0007
293 DRUG ABUSE 60 0.0007
294 LUNG CONSOLIDATION 2 0.0007
295 CELLULITIS 36 0.0007
296 PULMONARY ALVEOLAR HAEMORRHAGE 4 0.0007
297 BODY TEMPERATURE DECREASED 7 0.0007
298 INCORRECT DRUG ADMINISTRATION RATE 3 0.0007
299 NEUTROPENIC SEPSIS 5 0.0007
300 AGRANULOCYTOSIS 13 0.0007
301 HIATUS HERNIA 9 0.0007
302 ENTEROCOLITIS 4 0.0007
303 BLOOD URIC ACID INCREASED 4 0.0007
304 HYPONATRAEMIA 39 0.0007
305 ADENOVIRUS INFECTION 2 0.0007
306 RALES 4 0.0007
307 GASTROINTESTINAL NECROSIS 2 0.0007
308 AUTONOMIC NERVOUS SYSTEM IMBALANCE 2 0.0007
309 BLOOD CALCIUM INCREASED 6 0.0007
310 HYPOVOLAEMIA 4 0.0007
311 VULVOVAGINAL DISCOMFORT 3 0.0007
312 PSYCHIATRIC SYMPTOM 5 0.0007
313 RESPIRATORY RATE INCREASED 6 0.0007
314 ACUTE RESPIRATORY FAILURE 13 0.0007
315 RASH MACULO-PAPULAR 15 0.0007
316 INFUSION SITE REACTION 2 0.0007
317 BRAIN HERNIATION 2 0.0007
318 NORMOCHROMIC NORMOCYTIC ANAEMIA 2 0.0007
319 PAIN 404 0.0007
320 DYSCHEZIA 2 0.0007
321 MATERNAL DRUGS AFFECTING FOETUS 5 0.0007
322 HYPERCALCAEMIA 8 0.0006
323 FEELING OF DESPAIR 3 0.0006
324 INJECTION SITE HYPERSENSITIVITY 2 0.0006
325 PULMONARY HAEMORRHAGE 5 0.0006
326 BLOOD CREATININE DECREASED 2 0.0006
327 BLOOD LACTATE DEHYDROGENASE INCREASED 10 0.0006
328 BLADDER PAIN 2 0.0006
329 MALAISE 276 0.0006
330 FALL 209 0.0006
331 MALNUTRITION 7 0.0006
332 ENTERITIS 4 0.0006
333 ENTEROCOCCAL INFECTION 3 0.0006
334 CEREBRAL HAEMORRHAGE 22 0.0006
335 BACTERIAL SEPSIS 2 0.0006
336 HYPOVENTILATION 2 0.0006
337 NEUTROPHIL COUNT DECREASED 25 0.0006
338 LYMPHOCYTE COUNT INCREASED 2 0.0006
339 NASAL POLYPS 3 0.0006
340 LEUKOCYTOSIS 11 0.0006
341 ASPARTATE AMINOTRANSFERASE INCREASED 32 0.0006
342 CARDIAC FAILURE ACUTE 4 0.0006
343 HIGH DENSITY LIPOPROTEIN DECREASED 2 0.0006
344 ALTERED STATE OF CONSCIOUSNESS 13 0.0006
345 BK VIRUS INFECTION 2 0.0006
346 BACTERAEMIA 7 0.0006
347 HEPATIC CYST 2 0.0006
348 TACHYPNOEA 8 0.0006
349 CHOLECYSTITIS 7 0.0006
350 AUTOIMMUNE HAEMOLYTIC ANAEMIA 2 0.0006
351 BENIGN PROSTATIC HYPERPLASIA 3 0.0006
352 CERVICAL VERTEBRAL FRACTURE 2 0.0006
353 PERIORBITAL OEDEMA 3 0.0006
354 DEPRESSION SUICIDAL 2 0.0006
355 AUTOIMMUNE HEPATITIS 4 0.0006
356 HAEMOPTYSIS 16 0.0006
357 DRUG INTERACTION 91 0.0006
358 MUSCLE CONTRACTIONS INVOLUNTARY 2 0.0006
359 HYPOXIA 20 0.0006
360 PNEUMOTHORAX 9 0.0006
361 DUODENAL ULCER 4 0.0006
362 ACUTE RESPIRATORY DISTRESS SYNDROME 10 0.0006
363 HAEMORRHOIDS 11 0.0006
364 HYPOTHYROIDISM 18 0.0006
365 JAUNDICE 15 0.0006
366 ANAL INCONTINENCE 5 0.0006
367 BLOOD BILIRUBIN INCREASED 15 0.0006
368 ERYTHEMA OF EYELID 3 0.0006
369 CHRONIC GRAFT VERSUS HOST DISEASE 2 0.0006
370 ALANINE AMINOTRANSFERASE INCREASED 34 0.0006
371 C-REACTIVE PROTEIN INCREASED 20 0.0005
372 DEVICE KINK 2 0.0005
373 HYPERGLYCAEMIA 20 0.0005
374 DELIRIUM 19 0.0005
375 INTESTINAL ISCHAEMIA 3 0.0005
376 RESPIRATORY DISTRESS 15 0.0005
377 BLOOD PRESSURE DIASTOLIC DECREASED 4 0.0005
378 DRUG-INDUCED LIVER INJURY 17 0.0005
379 GAMMA-GLUTAMYLTRANSFERASE INCREASED 12 0.0005
380 HYPOPHOSPHATAEMIA 4 0.0005
381 LOWER GASTROINTESTINAL HAEMORRHAGE 4 0.0005
382 MENTAL IMPAIRMENT 13 0.0005
383 CEREBRAL INFARCTION 13 0.0005
384 INTESTINAL OBSTRUCTION 20 0.0005
385 CHOLECYSTITIS ACUTE 3 0.0005
386 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 9 0.0005
387 COMMUNICATION DISORDER 2 0.0005
388 LIPASE INCREASED 4 0.0005
389 ELECTROLYTE IMBALANCE 6 0.0005
390 APHTHOUS ULCER 4 0.0005
391 ACUTE HEPATIC FAILURE 7 0.0005
392 HYPOPHAGIA 13 0.0005
393 BRADYKINESIA 3 0.0005
394 COVID-19 PNEUMONIA 6 0.0005
395 PLATELET COUNT DECREASED 54 0.0005
396 IDIOPATHIC PULMONARY FIBROSIS 2 0.0005
397 RESPIRATORY TRACT CONGESTION 8 0.0005
398 PRESCRIBED UNDERDOSE 10 0.0005
399 CANDIDIASIS 2 0.0005
400 DRUG INEFFECTIVE 653 0.0005
401 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 3 0.0005
402 ASPHYXIA 4 0.0005
403 PARALYSIS 7 0.0005
404 ABNORMAL FAECES 4 0.0005
405 SPINAL COMPRESSION FRACTURE 4 0.0005
406 LOWER RESPIRATORY TRACT INFECTION 22 0.0005
407 HYPERTHYROIDISM 7 0.0005
408 EMBOLISM 4 0.0005
409 SECOND PRIMARY MALIGNANCY 4 0.0005
410 RESPIRATORY FAILURE 35 0.0005
411 ABDOMINAL PAIN LOWER 12 0.0005
412 RENAL PAIN 5 0.0005
413 ESCHERICHIA URINARY TRACT INFECTION 2 0.0005
414 CIRCULATORY COLLAPSE 8 0.0005
415 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 12 0.0005
416 MYOPATHY 4 0.0005
417 DYSURIA 17 0.0005
418 FAECES DISCOLOURED 10 0.0005
419 TOXIC EPIDERMAL NECROLYSIS 7 0.0005
420 DIABETIC KETOACIDOSIS 11 0.0005
421 BLOOD GLUCOSE FLUCTUATION 5 0.0005
422 HAEMORRHAGIC ANAEMIA 2 0.0005
423 HYPOKALAEMIA 21 0.0005
424 BLOOD TRIGLYCERIDES INCREASED 8 0.0005
425 MENINGITIS 3 0.0004
426 ATRIOVENTRICULAR BLOCK COMPLETE 3 0.0004
427 PANCYTOPENIA 25 0.0004
428 INTESTINAL PERFORATION 5 0.0004
429 BRONCHIECTASIS 3 0.0004
430 HAEMOGLOBIN DECREASED 45 0.0004
431 DRUG LEVEL ABOVE THERAPEUTIC 2 0.0004
432 NEPHROLITHIASIS 20 0.0004
433 OFF LABEL USE 381 0.0004
434 LARGE INTESTINE POLYP 3 0.0004
435 UPPER RESPIRATORY TRACT INFECTION 20 0.0004
436 LARGE INTESTINE PERFORATION 3 0.0004
437 HEPATIC ENCEPHALOPATHY 4 0.0004
438 CYTOMEGALOVIRUS INFECTION 7 0.0004
439 GASTRIC ULCER 8 0.0004
440 PROTEINURIA 8 0.0004
441 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 3 0.0004
442 NAUSEA 331 0.0004
443 WHITE BLOOD CELL COUNT INCREASED 16 0.0004
444 KIDNEY TRANSPLANT REJECTION 2 0.0004
445 MYELOSUPPRESSION 15 0.0004
446 HUMERUS FRACTURE 2 0.0004
447 HYPOKINESIA 6 0.0004
448 STOMATITIS 25 0.0004
449 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 7 0.0004
450 THROMBOTIC MICROANGIOPATHY 4 0.0004
451 PARKINSONISM 4 0.0004
452 RESPIRATORY DEPRESSION 5 0.0004
453 SMALL INTESTINAL OBSTRUCTION 5 0.0004
454 HEPARIN-INDUCED THROMBOCYTOPENIA 2 0.0004
455 MUCOUS STOOLS 2 0.0004
456 BLOOD ALKALINE PHOSPHATASE INCREASED 10 0.0004
457 IMMUNODEFICIENCY 6 0.0004
458 HYPERAMMONAEMIA 2 0.0004
459 BLOOD CREATININE INCREASED 26 0.0004
460 EPILEPSY 12 0.0004
461 HEPATIC CYTOLYSIS 5 0.0004
462 AMMONIA INCREASED 2 0.0004
463 THIRST 7 0.0004
464 OVERDOSE 84 0.0004
465 ANOREXIA 5 0.0004
466 LOW DENSITY LIPOPROTEIN INCREASED 3 0.0004
467 DELUSION 6 0.0004
468 VENTRICULAR EXTRASYSTOLES 4 0.0004
469 LETHARGY 22 0.0004
470 PRODUCT ADMINISTRATION INTERRUPTED 3 0.0004
471 CATATONIA 2 0.0004
472 HEAD INJURY 12 0.0004
473 ACUTE KIDNEY INJURY 58 0.0004
474 RENAL CYST 3 0.0004
475 CONJUNCTIVITIS 7 0.0004
476 NYSTAGMUS 2 0.0004
477 ASCITES 11 0.0004
478 FOOD POISONING 2 0.0004
479 COMPRESSION FRACTURE 2 0.0004
480 ANAL FISSURE 2 0.0004
481 LOCALISED INFECTION 9 0.0004
482 MYASTHENIA GRAVIS 3 0.0004
483 TACHYCARDIA 33 0.0004
484 GINGIVITIS 2 0.0004
485 POST PROCEDURAL INFECTION 3 0.0004
486 PNEUMONIA 118 0.0004
487 CENTRAL NERVOUS SYSTEM LESION 5 0.0004
488 CHOKING SENSATION 2 0.0004
489 HYPERKERATOSIS 2 0.0004
490 HEADACHE 227 0.0004
491 DENTAL CARIES 4 0.0004
492 PLEURAL EFFUSION 22 0.0004
493 ON AND OFF PHENOMENON 2 0.0004
494 EOSINOPHIL COUNT INCREASED 3 0.0004
495 WHITE BLOOD CELL COUNT DECREASED 39 0.0004
496 URINARY RETENTION 12 0.0004
497 URINARY TRACT INFECTION 61 0.0004
498 CANDIDA INFECTION 6 0.0004
499 EYE INFECTION 4 0.0004
500 SUBDURAL HAEMATOMA 5 0.0003
501 BLOOD MAGNESIUM DECREASED 3 0.0003
502 HERPES VIRUS INFECTION 2 0.0003
503 METASTASES TO LUNG 4 0.0003
504 CYSTITIS 11 0.0003
505 METABOLIC DISORDER 2 0.0003
506 HYPERKALAEMIA 12 0.0003
507 HYPERTRIGLYCERIDAEMIA 2 0.0003
508 LACTIC ACIDOSIS 11 0.0003
509 PURPURA 3 0.0003
510 PERITONITIS 7 0.0003
511 DRUG EFFECT LESS THAN EXPECTED 5 0.0003
512 COLON CANCER 5 0.0003
513 HAEMOLYTIC ANAEMIA 3 0.0003
514 DERMATITIS 7 0.0003
515 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 16 0.0003
516 HYPOAESTHESIA ORAL 5 0.0003
517 PRODUCT USE IN UNAPPROVED INDICATION 82 0.0003
518 THROMBOCYTOPENIA 37 0.0003
519 INGUINAL HERNIA 2 0.0003
520 RETINAL DETACHMENT 3 0.0003
521 DRUG ABUSER 2 0.0003
522 ANGER 11 0.0003
523 DEVICE RELATED INFECTION 5 0.0003
524 CHOLANGITIS 2 0.0003
525 SEPTIC SHOCK 14 0.0003
526 ERYTHEMA MULTIFORME 3 0.0003
527 TOOTH EXTRACTION 4 0.0003
528 HAEMATURIA 11 0.0003
529 APPENDICITIS 3 0.0003
530 DIARRHOEA HAEMORRHAGIC 3 0.0003
531 ACUTE MYELOID LEUKAEMIA 5 0.0003
532 EPSTEIN-BARR VIRUS INFECTION 2 0.0003
533 FLANK PAIN 3 0.0003
534 LEUKOPENIA 16 0.0003
535 NASAL DRYNESS 2 0.0003
536 ARTERIOSCLEROSIS 3 0.0003
537 HAEMATEMESIS 8 0.0003
538 STEVENS-JOHNSON SYNDROME 7 0.0003
539 DECREASED APPETITE 73 0.0003
540 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 3 0.0003
541 SUPRAVENTRICULAR TACHYCARDIA 3 0.0003
542 GASTROINTESTINAL HAEMORRHAGE 26 0.0003
543 HYPERCHOLESTEROLAEMIA 3 0.0003
544 SINUS BRADYCARDIA 3 0.0003
545 ABDOMINAL DISTENSION 32 0.0003
546 MUCOSAL INFLAMMATION 8 0.0003
547 ASPERGILLUS INFECTION 2 0.0003
548 HYPOGAMMAGLOBULINAEMIA 2 0.0003
549 SHOCK 7 0.0003
550 MALIGNANT NEOPLASM PROGRESSION 31 0.0003
551 HAEMATOCRIT DECREASED 6 0.0003
552 DRUG LEVEL INCREASED 5 0.0003
553 HYPOTONIA 3 0.0003
554 OVARIAN CYST 3 0.0003
555 SUBARACHNOID HAEMORRHAGE 3 0.0003
556 ECCHYMOSIS 2 0.0003
557 HYPOGLYCAEMIA 14 0.0003
558 SEPSIS 32 0.0003
559 CHEST PAIN 53 0.0003
560 RASH MACULAR 10 0.0003
561 SCRATCH 3 0.0003
562 BRADYCARDIA 15 0.0003
563 MOVEMENT DISORDER 9 0.0003
564 DECREASED ACTIVITY 3 0.0003
565 ELECTROCARDIOGRAM QT PROLONGED 10 0.0003
566 BLOOD CREATINE PHOSPHOKINASE INCREASED 8 0.0003
567 SWELLING FACE 18 0.0003
568 SKIN LACERATION 3 0.0003
569 DYSPNOEA 156 0.0003
570 FAECES SOFT 2 0.0003
571 CLOSTRIDIUM DIFFICILE INFECTION 6 0.0003
572 OESOPHAGITIS 3 0.0003
573 GASTROENTERITIS 4 0.0003
574 WOUND INFECTION 3 0.0003
575 INTENTIONAL UNDERDOSE 2 0.0003
576 HEPATITIS 7 0.0003
577 MOUTH HAEMORRHAGE 2 0.0003
578 MELAENA 6 0.0003
579 OEDEMA PERIPHERAL 33 0.0003
580 HAEMATOMA 7 0.0003
581 URINARY INCONTINENCE 8 0.0003
582 OBSTRUCTIVE AIRWAYS DISORDER 3 0.0003
583 DUODENAL ULCER PERFORATION 2 0.0003
584 RESPIRATORY TRACT INFECTION 7 0.0003
585 INTERSTITIAL LUNG DISEASE 13 0.0003
586 ECZEMA 14 0.0003
587 RESPIRATORY DISORDER 8 0.0003
588 OXYGEN SATURATION DECREASED 15 0.0003
589 VOMITING 124 0.0003
590 BLOOD URINE PRESENT 5 0.0003
591 DERMATITIS CONTACT 3 0.0003
592 NEUROPATHY PERIPHERAL 25 0.0003
593 HYPERTHERMIA 2 0.0003
594 MYOCARDITIS 3 0.0003
595 CHOLESTASIS 5 0.0003
596 RENAL FAILURE ACUTE 11 0.0003
597 FOOD ALLERGY 2 0.0003
598 OEDEMA 14 0.0003
599 EYELID OEDEMA 3 0.0003
600 APNOEA 2 0.0003
601 PLASMA CELL MYELOMA 10 0.0003
602 GASTROINTESTINAL INFLAMMATION 2 0.0003
603 AFFECTIVE DISORDER 2 0.0003
604 BLOOD IRON DECREASED 3 0.0003
605 DIVERTICULITIS 7 0.0003
606 MYOCLONUS 3 0.0003
607 SEIZURE 29 0.0003
608 HYPERLIPIDAEMIA 3 0.0003
609 ATRIAL FLUTTER 2 0.0003
610 WOUND 7 0.0003
611 BLOOD PRESSURE FLUCTUATION 6 0.0002
612 OBSESSIVE-COMPULSIVE DISORDER 2 0.0002
613 RHINORRHOEA 16 0.0002
614 BLOOD POTASSIUM INCREASED 4 0.0002
615 BODY TEMPERATURE INCREASED 5 0.0002
616 RED BLOOD CELL COUNT DECREASED 7 0.0002
617 METASTASES TO BONE 4 0.0002
618 PANCREATIC CARCINOMA 7 0.0002
619 DYSPHAGIA 23 0.0002
620 PHARYNGITIS 3 0.0002
621 ACUTE CORONARY SYNDROME 2 0.0002
622 DEHYDRATION 32 0.0002
623 SKIN DISORDER 8 0.0002
624 POLLAKIURIA 10 0.0002
625 SECRETION DISCHARGE 3 0.0002
626 DYSPHONIA 14 0.0002
627 HALLUCINATION, VISUAL 5 0.0002
628 MUSCLE ATROPHY 3 0.0002
629 FACIAL PARALYSIS 2 0.0002
630 IRRITABLE BOWEL SYNDROME 5 0.0002
631 ANURIA 2 0.0002
632 POOR QUALITY SLEEP 5 0.0002
633 INJECTION SITE INDURATION 3 0.0002
634 FLATULENCE 13 0.0002
635 EOSINOPHILIA 4 0.0002
636 GROIN PAIN 2 0.0002
637 TOOTH INFECTION 3 0.0002
638 COLD SWEAT 4 0.0002
639 LUNG INFILTRATION 2 0.0002
640 RENAL IMPAIRMENT 19 0.0002
641 DRUG ERUPTION 4 0.0002
642 TOOTH DISORDER 5 0.0002
643 GASTROINTESTINAL INFECTION 2 0.0002
644 PALLOR 6 0.0002
645 PNEUMONITIS 6 0.0002
646 GASTROINTESTINAL CARCINOMA 2 0.0002
647 IMPAIRED GASTRIC EMPTYING 3 0.0002
648 MUSCULAR WEAKNESS 25 0.0002
649 AGITATION 16 0.0002
650 BRAIN NEOPLASM 2 0.0002
651 IRON DEFICIENCY ANAEMIA 2 0.0002
652 INTERVERTEBRAL DISC DEGENERATION 2 0.0002
653 ORAL DISCOMFORT 3 0.0002
654 FEELING COLD 6 0.0002
655 COORDINATION ABNORMAL 3 0.0002
656 SOMNOLENCE 43 0.0002
657 HEPATIC CIRRHOSIS 4 0.0002
658 DIARRHOEA 137 0.0002
659 SEASONAL ALLERGY 3 0.0002
660 ARRHYTHMIA 10 0.0002
661 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 11 0.0002
662 PULMONARY EMBOLISM 20 0.0002
663 THERAPY INTERRUPTED 15 0.0002
664 SLEEP APNOEA SYNDROME 4 0.0002
665 PRODUCTIVE COUGH 10 0.0002
666 ANGINA PECTORIS 6 0.0002
667 INCREASED APPETITE 4 0.0002
668 GLAUCOMA 4 0.0002
669 NEURALGIA 5 0.0002
670 HEPATOMEGALY 2 0.0002
671 ACUTE MYOCARDIAL INFARCTION 6 0.0002
672 HYPERTENSION 43 0.0002
673 LIGAMENT SPRAIN 2 0.0002
674 CATARACT 12 0.0002
675 PULMONARY MASS 3 0.0002
676 EXTRAPYRAMIDAL DISORDER 5 0.0002
677 EPISTAXIS 15 0.0002
678 AGEUSIA 5 0.0002
679 COUGH 56 0.0002
680 BLOOD POTASSIUM DECREASED 6 0.0002
681 CYTOKINE RELEASE SYNDROME 4 0.0002
682 HOT FLUSH 15 0.0002
683 GENERAL PHYSICAL HEALTH DETERIORATION 23 0.0002
684 EMPHYSEMA 2 0.0002
685 ECONOMIC PROBLEM 3 0.0002
686 DYSKINESIA 8 0.0002
687 NECK PAIN 11 0.0002
688 LUNG INFECTION 3 0.0002
689 EYE DISCHARGE 2 0.0002
690 PULMONARY HYPERTENSION 4 0.0002
691 INJECTION SITE DISCOMFORT 2 0.0002
692 INJECTION SITE MASS 7 0.0002
693 EATING DISORDER 4 0.0002
694 RETCHING 4 0.0002
695 CARDIAC FAILURE 15 0.0002
696 HIP FRACTURE 6 0.0002
697 HYPOACUSIS 8 0.0002
698 MENTAL DISORDER 8 0.0002
699 IMPAIRED HEALING 6 0.0002
700 ASPIRATION 2 0.0002
701 SKIN LESION 5 0.0002
702 INJECTION SITE NODULE 2 0.0002
703 RESPIRATORY ARREST 5 0.0002
704 MENTAL STATUS CHANGES 5 0.0002
705 FUNGAL INFECTION 6 0.0002
706 HYPERTENSIVE CRISIS 2 0.0002
707 LOSS OF CONSCIOUSNESS 23 0.0002
708 CHILLS 21 0.0002
709 THROAT IRRITATION 8 0.0002
710 PANCREATITIS ACUTE 4 0.0002
711 FACE OEDEMA 3 0.0002
712 CHROMATURIA 4 0.0002
713 MICTURITION URGENCY 2 0.0002
714 GASTRIC HAEMORRHAGE 2 0.0002
715 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 4 0.0002
716 DIABETES MELLITUS 13 0.0002
717 SYNCOPE 17 0.0002
718 HOSPITALISATION 26 0.0002
719 NEUTROPENIA 23 0.0002
720 DISEASE PROGRESSION 20 0.0002
721 WHEEZING 10 0.0002
722 BACK PAIN 39 0.0002
723 GOUT 3 0.0002
724 HEPATIC FAILURE 5 0.0002
725 OSTEOMYELITIS 3 0.0002
726 HEPATITIS C 2 0.0002
727 COVID-19 29 0.0002
728 ADRENAL INSUFFICIENCY 2 0.0002
729 NOCTURIA 2 0.0002
730 RESTLESSNESS 6 0.0002
731 LIVER INJURY 4 0.0002
732 ANAPHYLACTIC REACTION 9 0.0002
733 BRONCHITIS 12 0.0002
734 GASTROOESOPHAGEAL REFLUX DISEASE 13 0.0002
735 FEMUR FRACTURE 5 0.0002
736 HEPATIC STEATOSIS 3 0.0002
737 HAIR COLOUR CHANGES 2 0.0002
738 MUSCULOSKELETAL STIFFNESS 14 0.0002
739 BLOOD SODIUM DECREASED 3 0.0002
740 LIVER DISORDER 7 0.0002
741 HERPES ZOSTER 9 0.0002
742 INTRAOCULAR PRESSURE INCREASED 2 0.0002
743 POST PROCEDURAL COMPLICATION 3 0.0002
744 EAR PAIN 3 0.0002
745 ASTHENIA 58 0.0002
746 CHOKING 3 0.0002
747 NASAL CONGESTION 9 0.0002
748 SPEECH DISORDER 8 0.0002
749 GASTRITIS 4 0.0002
750 IMMUNE SYSTEM DISORDER 2 0.0002
751 SINUS DISORDER 3 0.0002
752 ABNORMAL BEHAVIOUR 6 0.0002
753 ADVERSE REACTION 2 0.0002
754 ABDOMINAL PAIN UPPER 31 0.0002
755 BLOOD PRESSURE DECREASED 10 0.0002
756 INTENTIONAL SELF-INJURY 3 0.0001
757 DYSGEUSIA 11 0.0001
758 FEEDING DISORDER 3 0.0001
759 DRY MOUTH 12 0.0001
760 TASTE DISORDER 3 0.0001
761 GINGIVAL BLEEDING 2 0.0001
762 HALLUCINATION 11 0.0001
763 RIB FRACTURE 3 0.0001
764 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 8 0.0001
765 HAEMORRHAGE 15 0.0001
766 LYMPHOPENIA 2 0.0001
767 MULTIPLE ORGAN DYSFUNCTION SYNDROME 4 0.0001
768 JOINT INJURY 3 0.0001
769 BRONCHOSPASM 2 0.0001
770 SKIN CANCER 3 0.0001
771 PRODUCT USE ISSUE 26 0.0001
772 INTERVERTEBRAL DISC PROTRUSION 3 0.0001
773 DYSSTASIA 4 0.0001
774 THROMBOSIS 11 0.0001
775 GAIT DISTURBANCE 26 0.0001
776 CEREBROVASCULAR ACCIDENT 23 0.0001
777 PRURITUS 52 0.0001
778 DRUG WITHDRAWAL SYNDROME NEONATAL 2 0.0001
779 CONTUSION 13 0.0001
780 TRANSAMINASES INCREASED 3 0.0001
781 HEPATOTOXICITY 3 0.0001
782 HAEMORRHAGE INTRACRANIAL 2 0.0001
783 ADVERSE DRUG REACTION 12 0.0001
784 DYSARTHRIA 5 0.0001
785 HEPATIC ENZYME INCREASED 9 0.0001
786 SUICIDE ATTEMPT 8 0.0001
787 URTICARIA 22 0.0001
788 HEART RATE INCREASED 13 0.0001
789 ABDOMINAL DISCOMFORT 22 0.0001
790 INSURANCE ISSUE 2 0.0001
791 SKIN DISCOLOURATION 6 0.0001
792 DISORIENTATION 5 0.0001
793 INFLUENZA 14 0.0001
794 OBESITY 2 0.0001
795 RASH ERYTHEMATOUS 6 0.0001
796 METABOLIC ACIDOSIS 4 0.0001
797 INFECTION 18 0.0001
798 ASTHMA 14 0.0001
799 ENCEPHALOPATHY 3 0.0001
800 OSTEOPOROSIS 5 0.0001
801 STAPHYLOCOCCAL INFECTION 4 0.0001
802 CARDIAC ARREST 10 0.0001
803 GENERALISED TONIC-CLONIC SEIZURE 2 0.0001
804 INSOMNIA 32 0.0001
805 CARDIO-RESPIRATORY ARREST 5 0.0001
806 BONE PAIN 7 0.0001
807 PAIN IN EXTREMITY 35 0.0001
808 GASTRIC CANCER 3 0.0001
809 OSTEOARTHRITIS 5 0.0001
810 ERECTILE DYSFUNCTION 3 0.0001
811 DRUG RESISTANCE 3 0.0001
812 UNRESPONSIVE TO STIMULI 3 0.0001
813 RASH GENERALISED 3 0.0001
814 MULTI-ORGAN FAILURE 2 0.0001
815 NIGHTMARE 4 0.0001
816 NEOPLASM PROGRESSION 4 0.0001
817 VERTIGO 7 0.0001
818 DEAFNESS 3 0.0001
819 LOCAL SWELLING 2 0.0001
820 MUSCULOSKELETAL PAIN 6 0.0001
821 DEVICE USE ISSUE 2 0.0001
822 NEUROTOXICITY 2 0.0001
823 METASTASES TO LIVER 2 0.0001
824 HYPOAESTHESIA 17 0.0001
825 DEPRESSED MOOD 6 0.0001
826 DIABETES MELLITUS INADEQUATE CONTROL 2 0.0001
827 RENAL FAILURE 15 0.0001
828 CONFUSIONAL STATE 18 0.0001
829 BLOOD PRESSURE INCREASED 17 0.0001
830 LIMB INJURY 3 0.0001
831 OROPHARYNGEAL PAIN 10 0.0001
832 RASH 47 0.0001
833 RENAL DISORDER 5 0.0001
834 BACTERIAL INFECTION 2 0.0001
835 PAIN IN JAW 3 0.0001
836 ARTHRALGIA 44 0.0001
837 FOOT FRACTURE 2 0.0001
838 HYPERSOMNIA 3 0.0001
839 LOWER LIMB FRACTURE 2 0.0001
840 HERNIA 2 0.0001
841 NASOPHARYNGITIS 19 0.0001
842 NEEDLE ISSUE 3 0.0001
843 TREMOR 17 0.0001
844 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 3 0.0001
845 SURGERY 6 0.0001
846 DIZZINESS 51 0.0001
847 LUNG DISORDER 5 0.0001
848 VISION BLURRED 14 0.0001
849 ARTHRITIS 8 0.0001
850 LABORATORY TEST ABNORMAL 3 0.0001
851 PSYCHOTIC DISORDER 3 0.0001
852 BLOOD GLUCOSE INCREASED 19 0.0001
853 AGGRESSION 5 0.0001
854 BURNING SENSATION 7 0.0001
855 FULL BLOOD COUNT DECREASED 2 0.0001
856 PSORIATIC ARTHROPATHY 4 0.0001
857 BONE MARROW FAILURE 2 0.0001
858 ADVERSE EVENT 9 0.0001
859 DRY SKIN 13 0.0001
860 INJECTION SITE WARMTH 2 0.0001
861 TREATMENT FAILURE 8 0.0001
862 FATIGUE 75 0.0001
863 NERVOUS SYSTEM DISORDER 3 0.0001
864 UNDERDOSE 7 0.0001
865 NERVOUSNESS 5 0.0001
866 CONDITION AGGRAVATED 29 0.0001
867 MOUTH ULCERATION 2 0.0001
868 PANCREATITIS 5 0.0001
869 LIVER FUNCTION TEST INCREASED 2 0.0001
870 UNEVALUABLE EVENT 7 0.0001
871 ATRIAL FIBRILLATION 9 0.0001
872 DEEP VEIN THROMBOSIS 6 0.0001
873 CHRONIC KIDNEY DISEASE 7 0.0001
874 DEVICE DISLOCATION 4 0.0001
875 CHOLELITHIASIS 3 0.0001
876 TREATMENT NONCOMPLIANCE 5 0.0001
877 INTENTIONAL PRODUCT MISUSE 8 0.0001
878 PERIPHERAL SWELLING 14 0.0001
879 VISUAL ACUITY REDUCED 3 0.0001
880 VIRAL INFECTION 3 0.0001
881 GAIT INABILITY 3 0.0001
882 GLOSSODYNIA 2 0.0001
883 ORAL PAIN 2 0.0001
884 GASTROINTESTINAL DISORDER 8 0.0001
885 PARAESTHESIA 14 0.0001
886 CHEST DISCOMFORT 9 0.0001
887 CONVULSION 5 0.0001
888 SUICIDAL IDEATION 8 0.0001
889 ILLNESS 9 0.0001
890 PALPITATIONS 10 0.0001
891 WEIGHT INCREASED 19 0.0001
892 LYMPHADENOPATHY 3 0.0001
893 BLOOD GLUCOSE DECREASED 4 0.0001
894 JOINT SWELLING 10 0.0001
895 CRYING 3 0.0001
896 PANIC ATTACK 3 0.0001
897 FEELING HOT 5 0.0001
898 OSTEONECROSIS OF JAW 2 0.0001
899 EYE SWELLING 3 0.0001
900 DYSPNOEA EXERTIONAL 3 0.0001
901 GLYCOSYLATED HAEMOGLOBIN INCREASED 2 0.0001
902 SINUSITIS 8 0.0001
903 DEVICE ISSUE 7 0.0001
904 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 14 0.0001
905 ANXIETY 22 0.0001
906 DIPLOPIA 2 0.0001
907 MYALGIA 13 0.0001
908 JOINT STIFFNESS 2 0.0001
909 ANHEDONIA 2 0.0001
910 EAR INFECTION 2 0.0001
911 NEOPLASM MALIGNANT 5 0.0001
912 BREAST CANCER FEMALE 2 0.0001
913 DEPRESSION 17 0.0001
914 CARDIAC FAILURE CONGESTIVE 6 0.0001
915 FEAR 2 0.0001
916 DEATH 64 0.0001
917 MIGRAINE 7 0.0001
918 ROAD TRAFFIC ACCIDENT 3 0.0001
919 BLISTER 4 0.0001
920 INJURY 5 0.0001
921 INTENTIONAL DOSE OMISSION 2 0.0001
922 INTERNATIONAL NORMALISED RATIO INCREASED 2 0.0001
923 HYPERSENSITIVITY 13 0.0001
924 HYPERHIDROSIS 9 0.0001
925 EYE IRRITATION 4 0.0001
926 LIVER FUNCTION TEST ABNORMAL 2 0.0001
927 ANGIOEDEMA 3 0.0001
928 MATERNAL EXPOSURE DURING PREGNANCY 6 0.0001
929 THERAPY NON-RESPONDER 3 0.0001
930 IRRITABILITY 4 0.0001
931 APHASIA 2 0.0001
932 LACRIMATION INCREASED 2 0.0001
933 ALOPECIA 13 0.0001
934 CONTRAINDICATED PRODUCT ADMINISTERED 2 0.0001
935 CORONARY ARTERY DISEASE 2 0.0001
936 THERAPEUTIC RESPONSE DECREASED 4 0.0001
937 TINNITUS 3 0.0001
938 VISUAL IMPAIRMENT 8 0.0001
939 BLOOD CHOLESTEROL INCREASED 3 0.0001
940 OCULAR HYPERAEMIA 3 0.0001
941 FEELING ABNORMAL 15 0.0001
942 FOETAL EXPOSURE DURING PREGNANCY 5 0.0001
943 EYE DISORDER 2 0.0001
944 INFLUENZA LIKE ILLNESS 5 0.0001
945 DRY EYE 3 0.0001
946 LIP SWELLING 2 0.0001
947 MUSCLE SPASMS 11 0.0001
948 SKIN EXFOLIATION 5 0.0001
949 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 2 0.0001
950 FLUSHING 6 0.0001
951 MEMORY IMPAIRMENT 8 0.0001
952 EMOTIONAL DISTRESS 7 0.0001
953 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 4 0.0001
954 RASH PRURITIC 3 0.0001
955 DRUG EFFECT INCOMPLETE 2 0.0001
956 EYE PAIN 3 0.0001
957 DRUG INTOLERANCE 5 0.0001
958 INJECTION SITE HAEMORRHAGE 4 0.0001
959 ABORTION SPONTANEOUS 2 0.0000
960 DISCOMFORT 3 0.0000
961 BLINDNESS 2 0.0000
962 INJECTION SITE PAIN 15 0.0000
963 LUNG NEOPLASM MALIGNANT 2 0.0000
964 INTENTIONAL OVERDOSE 3 0.0000
965 DEVICE LEAKAGE 2 0.0000
966 MYOCARDIAL INFARCTION 8 0.0000
967 INTENTIONAL PRODUCT USE ISSUE 4 0.0000
968 PRODUCT DOSE OMISSION ISSUE 13 0.0000
969 CARDIAC DISORDER 4 0.0000
970 SLEEP DISORDER 3 0.0000
971 DISEASE RECURRENCE 2 0.0000
972 COMA 2 0.0000
973 SKIN BURNING SENSATION 3 0.0000
974 FLUID RETENTION 2 0.0000
975 INFLAMMATION 2 0.0000
976 DISTURBANCE IN ATTENTION 2 0.0000
977 ARTHROPATHY 2 0.0000
978 MEDICATION ERROR 2 0.0000
979 EXPOSURE DURING PREGNANCY 2 0.0000
980 AMNESIA 2 0.0000
981 PSORIASIS 4 0.0000
982 ACCIDENTAL EXPOSURE TO PRODUCT 3 0.0000
983 INJECTION SITE REACTION 2 0.0000
984 RHEUMATOID ARTHRITIS 3 0.0000
985 DRUG DEPENDENCE 4 0.0000
986 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 5 0.0000
987 INCORRECT DOSE ADMINISTERED 5 0.0000
988 BREAST CANCER 2 0.0000
989 INJECTION SITE ERYTHEMA 2 0.0000
990 NO ADVERSE EVENT 2 0.0000